NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport
- 31 August 2013
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 56, 79-94
- https://doi.org/10.1016/j.nbd.2013.04.012
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathyMolecular Psychiatry, 2013
- Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosisNature, 2012
- Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRINeuroImage, 2012
- 1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosisNMR in Biomedicine, 2011
- Mice with Mutation in Dynein Heavy Chain 1 Do Not Share the Same Tau Expression Pattern with Mice with SOD1-Related Motor Neuron DiseaseNeurochemical Research, 2011
- Manganese-Enhanced Magnetic Resonance Imaging (MEMRI)Methods in Molecular Biology, 2010
- R-flurbiprofen improves axonal transport in the Tg2576 mouse model of Alzheimer's Disease as determined by MEMRIMagnetic Resonance in Medicine, 2010
- TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degenerationProceedings of the National Academy of Sciences of the United States of America, 2009
- In vivo axonal transport rates decrease in a mouse model of Alzheimer's diseaseNeuroImage, 2007
- Mesopontine cholinergic projections to the hypoglossal motor nucleusNeuroscience Letters, 2007